Production (Stage)
Capricor Therapeutics, Inc.
CAPR
$12.07
-$0.31-2.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -55.06M | -40.47M | -34.11M | -27.95M | -24.31M |
| Total Depreciation and Amortization | 1.50M | 1.43M | 1.36M | 1.27M | 1.17M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.45M | 9.83M | 9.29M | 8.97M | 8.44M |
| Change in Net Operating Assets | -4.04M | -10.78M | -13.33M | -16.24M | -16.37M |
| Cash from Operations | -45.16M | -40.00M | -36.79M | -33.95M | -31.08M |
| Capital Expenditure | -2.01M | -1.54M | -1.53M | -2.11M | -2.26M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -80.78M | -114.64M | 2.87M | 9.16M | 1.08M |
| Cash from Investing | -82.79M | -116.18M | 1.34M | 7.05M | -1.18M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 150.53M | 152.77M | 94.85M | 27.75M | 27.87M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 150.53M | 152.77M | 94.85M | 27.75M | 27.87M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 22.58M | -3.41M | 59.39M | 851.20K | -4.39M |